SR17018

SR-17018 is a synthetic research chemical that acts as an atypical, G-protein-biased agonist of the μ-opioid receptor (MOR). Developed by scientists at Scripps Research, it is highly studied in neuropharmacology for its potential to provide potent pain relief with a significantly reduced risk of overdose and addiction compared to conventional opioids like morphine or fentanyl.